| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |